ArticleBMC medical ethics2020

Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.

Sebastian Schleidgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.